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PREWEANING PROCESSINGANTHELhlINTIC TREATMENT AND POSTWEANING 
EFFECTS OF SULFAMETWV1NE BASED MEDlCATlONS ON PERFORMANCE 
TRAITS AND OOCYST SHEDDING IN WEANED CALVES 
R. H. ~ritchard' 
Departments of Animal 
Summary 
Two trials were conducted to evaluate antibiotic 
therapies for feeder calves originating in western 
South Dakota. In Trial 1, processing-anthelmintic 
treatment 28 days before weaning reduced ranch gains 
and provided no advantage in feedlot gains when 
calves were reprocessed. Processing included 
deworming, grubicide treatment, implanting and 
vaccination. Sulfamethazine medication caused 
transient improvements in feedlot performance during 
the feedlot receiving period in both trials. 
Supertherapeutic treatment with AS 700 offered no 
advantage in feedlot performance over therapeutic 
feeding in these calves. Sulfamethazine exposure 
suppressed coccidia oocyst shedding and appears to 
be an effective means of controlling coccidiosis and 
shipping fever complex for newly received calves. 
(Key Words: Calves, Sulfamethazine, Coccidiosis, 
Shipping Stress, Parasites.) 
Introduction 
The initial 4 weeks in the feedlot represent a 
critical period for recently weaned feeder calves. 
Stresses due to weaning, shipping, parasite burden, 
vaccination, exposure to pathogens and reduced feed 
intake increase susceptibility to disease. Respiratory 
illness and coccidiosis represent the two most common 
problems when managing these calves. Calf receiving 
programs that minimize losses to these problems are 
critical to successful feeding. The fficacy of sulfa f based medications such as AS 700 for controlling 
shipping fever has been established. These products 
may also suppress coccidiosis. Two feeding trials were 
conducted to determine i f  sutfamethazine medication 
would reduce disease and enhance performance of 
calves infected with coccidiosis. 
, J. U. ~homson' and M. A. ~obbins* 
and Range Sciences and Veterinary Science 
Materials and Methods 
Feeding trials were conducted in the fall of 1988 
and 1989. Calves were obtained from the same ranch 
each year. It was previously established that many of 
these calves were infected with coccidia. 
Trial 1. Crossbred steer and heifer calves 
(48 head each) were weighed on the ranch and allotted 
to receive preshipment processing or as controls. The 
treated calves were vaccinated against IBR, BVD, PI 9' Hemophilu somnus and a ?-way clostridia. Warbex , 
Levamisol3 and FIalgro4 implants were also 
administered at this time. All calves were then 
comingled for 28 days before weaning. 
At weaning, 32 additional steers that had 
received the vaccination and parasite treatments were 
added as a second group for inclusion in postshipment 
treatments. All calves were weighed and half of the 
calves from ach sex, vaccination and group received 5 three Sulmet boluses before being loaded on trucks 
and shipped 350 miles to the SDSU research feedlot 
near Brookings. 
In the feedyard, calves stood overnight with 
access to long stemmed grass hay and water. The 
next morning all calves received the same vaccinations 
as were used on the ranch. Previously unimplanted 
calves received a Ralgro implant. Sulmet boluses (3) 
were again administered to those calves bolused 
preshipment. Calves were sorted into 8-head pens by 
vaccination and Sulmet treatment groups. Steer and 
heifer calves were mixed within pens. The feedlot 
receiving diet was based on corn silage Fable 1). 
AS 700 was fed at therapeutic levels to half of the 
calves and was balanced across previous treatments. 
AS 700 feeding was continued at a constant dosage for 
27 days. Performance data on the ranch were based 
'~ssociate Professor. 
' ~ a n a ~ e r ,  Beef Cattle and Sheep Nutrition Unit. 
'~merican Cyanamid, Wayne, NJ 07470. 
4~ i tman-~oore ,  Terre Haute, IN 47808. 
TABLE 1. DIETS FED TO CALVES DURING FEEDLOT 
PERFORMANCE  TEST^ 
lnqredient ~8840-RbC, % ~8840-2 '~ ,  %
Ground hay 
Corn silage 
Supplement 
Soybean meal, 44% 
Trace mineralized salte 
Limestone 
Dicalcium phosphate 
a Percent dry matter basis. 
Fed 1 to 27 days after arrival. In Trial 1, diet was top-dressed with .5 
Iblheadlday ground corn that did or did not contain 9.08 g AS 7001lb. In 
Trial 2, medication top-dressed as 6.67% diet, DMB. 
Diets contained 1,000 IU per Ib supplemental vitamin A. 
Diet provides 27 g D  monensin. Fed after initial 27 days. 
Contains NaCl >93%, Zn >.35%, Mn >.28%, Fe >.175%, Cu >.035%, 1 
>.007%. Co >.007%. 
on individual calf responses. Feedlot performance data 
were analyzed on a pen mean basis using procedures 
appropriate for a 2 x 2 x 2 factorial arrangement of 
treatments. 
Trial 2. One hundred thirty-one steer calves 
were shipped directly from the ranch to the Brookings 
feedlot without any preshipment treatment. Receiving 
conditions and diet were the same as for Trial 3. All 
calves received similar vaccinations, but lvomec was 
used for anthelmintic treatment in this trial. Allotment 
was based upon a weight stratification providing 
15 pens of 8 head. Eleven steers were randomly 
selected to be removed from the experiment to balance 
pen concentrations. 
Premixes were prepared to contain (A) 0, 
(B) 1.98 or (C) 5.94 glkg AS 700 Uable 2). These 
premixes were top-dressed at 6.67% of diet dry matter. 
If dry matter intake (DMI) during this period was IS%, 
body weight treatment B would provide therapeutic 
levels of AS 700. If DM1 was .5%, body weight 
treatment C would provide therapeutic levels of AS 700. 
On day 11, premix C was discontinued and premix B 
was used in its place. Feeding premixes A and B was 
discontinued after 27 days. Performance data were 
analyzed on a pen mean basis by procedures 
appropriate for a completely random designed 
experiment. 
In both studies, fecal samples were obtained 
from all steers twice weekly for the initial 4 weeks in the 
feedlot. Oocyst countslgram fresh feces were 
determined and categorized as clean, 0 oocystslg; low, 
1 to 99 oocystslg; moderate, 100 to 499 oocysts; and 
heavy, ~ 4 9 9  oocystslg. The frequency of occurrence 
in each infestation category was compared among 
treatments by Chi square analysis. 
Premix 
Item A B C 
Ground corn 136 1 33 128 
AS 700 0 2.724 8.172 
Vegetable oil 1.26 1.36 1.36 
AS 700 concentration, @kg 0 1.98 5.94 
a Kg, as fed basis. 
5~~~ AgVet, Rahway, NJ 07065. 
ResuRs and Discussion -- 
The on ranch processing depressed gains (2.30 
vs 2.08 Ibtday, Pe.05) on the ranch in Trial 1. We have 
observed this response in previous trials on an 
inconsistent basis. In previous studies, a Ralgro 
implant 4 weeks preshipment improved gains. Other 
processing treatments were not confounded with 
anabolic implants in those studies. 
Calves vaccinated on the ranch actually received 
this treatment twice. We took this approach since it is 
typical for a feedyard to vaccinate all incoming cattle 
regardless of reported medical history. During the 
period from 28 to 55 days after feedlot arrival, calves 
vaccinated preshipment had lower average daily gains 
(2.53 vs 2.29; Pe.05) and higher feed conversions (5.57 
vs 6.18; Pe.05) than controls. After 83 days, this 
response had diminished. A similar response was 
noted when gains were calculated for the period of 
initial ranch processing through 83 days in the 
feedyard. 
Dosing with Sulmet boluses depressed gains 
(3.24 vs 3.01; Pe.05) during the initial 28 days in the 
feedlot (Table 3), Intake was not affected by bolusing. 
The reason for the lowered average daily gain (ADG) is 
unclear. Calves made up this difference by 55 days. 
Feeding AS 700 improved ADG (2.98 vs 3.28; 
Pe.05) during the initial 27 days on feed and increased 
DM1 (13.73 vs 14.36; P<.05) during 28 to 55 days on 
feed. After 83 days on corn silage diets, these 
responses had disappeared. 
Interactions occurred (P< .05) between bolusing 
and AS 700 for DM1 from 28 to 55 days, where cattle 
receiving one medication treatment consumed more 
feed than those receiving no medication or those 
receiving both forms of medication (Table 3). ADG from 
56 to 83 days responded similarly. These data suggest 
that in the absence of acute disease only one avenue 
of medication should be utilized. 
TABLE 3. EFFECTS OF SULMET BOLUS AND AS 700 ON FEEDLOT 
PERFORMANCE OF FEEDER CALVES, TRIAL 1 
Sulmet boluses No 
AS 700 No Yes No Yes 
Yes 
1 to 27 ays 
A D G ~  I! 
DMF 
FIG 
28 to 55 days 
ADG 
D M I ~ ~  
FIG 
56 to 9 days 
ADG 
DM1 
FIG 
1 to 83 days 
ADG 
D M I ~  
FIG 
AS 700 effect (P< .05). 
BOIUS effect (P<.IO). 
AS 700 effect (P < .I 0). 
AS 700 x bolus effect (Pe.05). 
An interaction also existed between processing- 
anthelmintic and AS 700 treatments for feed conversion 
from 55 to 83 days and overall (Table 4). Feed 
conversion was higher when calves received 
preweaning vaccinations and AS 700 in the receiving 
period. 
In Trial 2, intake was good, resulting in high 
medication intakes during the initial 10 days in the 
feedlot (Table 5). Feeding AS 700 increased (P<.10) 
steer weights at 27 days and DM1 after the initial 
27 days (Table 6). Most of the increase in gain 
occurred during the initial 13 days in the feedlot. Feed 
conversion was also improved due to AS 700 feeding 
over the 13- (Pc.05) and 27-day (Pq.10) periods. The 
high dosage of AS 700 depressed feed intake (Pq.10) 
throughout the receiving period. Using this approach 
to medicating diets does not help and may hinder 
performance if calves take to feed readily. 
In both studies sutfamethazine reduced the 
frequency of calves shedding moderate and high 
amounts of oocysts. Sulmet treatment reduced 
shedding (Pq.05) at 2, 5, 9 and 12 days after feedlot 
arrival in Trial 1 (Table 7). AS 700 reduced oocyst 
shedding on days 5 (Pc.05), 9 (P<.10), 12 (P<.10), 23 
(Pc.01) and 26 (P<.10). In Trial 2 (Table 8), oocyst 
shedding was suppressed uniformly throughout the 
collection period. Supertherapeutic medication 
enhanced this response over therapeutic medication 
levels. In both studies monensin was included in diets 
at 20 gfl after AS 700 was withdrawn and subsequent 
fecal samples contained minimal incidence of oocyst 
shedding. 
No significant incidence of respiratory illness or 
acute coccidiosis occurred in either of these trials. 
AS 700 treatment at therapeutic levels tended to 
improve catf performance and suppressed oocyst 
shedding. The higher level of AS 700 feeding was not 
efficacious for improving performance but may provide 
greater protection against coccidiosis. Other research 
has shown advantages to supertherapeutic treatment. 
Level of feed intake may be an imponant consideration 
in selecting medication therapy. 
In our receiving studies, cakes have been in the 
marketing channels for less than 48 hours. The 
imponance of a preweaning processing program may 
differ in groups of cattle exposed to a longer transition 
time from the ranch to the feedlot or other stresses. 
TABLE 4. EFFECTS OF PREWEANING PROCESSING AND POSTWEANING 
SULMET BOLUS AND AS 700 ON FEEDLOT PERFORMANCE OF 
FEEDER CALVES, TRIAL 1 
Presh~pment vaccinat~on No Yes 
AS 700 No Yes No Yes 
1 to 27 days 
A D G ~  
D M I ~  
FIG 
28 to 55 days 
A D G ~  
DM1 
FIG 
56 to 83 days 
A D G ~  
DM1 
 FIG^ 
1 to 83 days 
A D 2  
DM1 
 FIG^ 
a AS 700 effect (P<.05). 
AS 700 effect (P<.10). 
Vaccination effect (P<.10). 
Vaccination effect (PC .05). 
AS 700 x vaccination effect (Pc.05). 
TABLE 5. DAILY DRY MAlTER INTAKE AND DRUG CONCENTRATION BY TREATMENT  GROUP^ 
B
Dry matter 
C
Drug Dry maler Drugb Dry matter Drug 
Dav intake intakeb intake intake intake intakeb 
Mean of five pens. 
Mglhead of chlortetracycline + sulfamethazine. 
TABLE 6. FEEDLOT RECEIVING PERIOD PERFORMANCE OF STEER CALVES, TRIAL 2 
f reat ment A B C SEM 
Steer weight 
Initial 
Day 10 
Day 13 
Day 27a 
Day 
Average daily gain 
Days 1-10 
Days 1 - 1 3 ~  
Days 14-2g 
Days 1-27b 
Days 1-34 
Dry matter intake 
Days 1-13' 
Days 14-27a 
Days 1-27aC 
Days 1-34 
Feedlgain 
Days 1 - 1 3 ~  
Days 14-27 
Days 1-27a 
Days 1 - 3 4 ~  
TABLE 7. CHI-SQUARE ANALYSIS OF OOCYST SHEDDING FREQUENCIES BY 
SULMET BOLUS AND AS 700 TREATMENTS, TRIAL 1 
Bolus No No Yes Yes No Yes 
AS 700 No Yes No Yes No Yes 
Sample 
date Number of calves 
Initial 
Day 0 
Day 2bd 0 11 7 26 22 18 48 37 29 
1-99 10 17 3 10 27 13 13 27 
100-499 4 6 1 0 10 1 5 6 
>499 3 2 1 0 5 1 4 2 
Day 5bM 0 6 13 15 24 19 39 21 37 
1-99 12 10 13 7 22 20 25 17 
100-499 8 7 3 1 15 4 11 8 
>499 6 2 0 0 8 0 6 2 
Day gde 0 8 14 27 24 22 5 1 35 38 
1-99 14 11 5 5 25 10 19 16 
100-499 1 4 0 0 5 0 1 4 
>499 8 1 0 0 9 0 8 1 
Day 12ace 
Day 17 
Day 19 0 19 26 21 21 4 5 42 40 47 
1-99 5 1 2 6 6 8 7 7 
100-499 4 3 5 2 7 7 9 5 
> 499 1 0 4 1 1 5 5 1 
Day 221ag 0 15 24 14 23 39 37 29 47 
1-99 10 3 10 5 13 15 20 8 
100-499 5 1 5 1 6 6 10 2 
>499 1 0 1 0 1 1 2 0 
TABLE 7 CONTINUED 
UOIUS NO NO yes yes NO yes 
AS 700 No Yes No Yes No Yes 
Sample 
date Number of calves 
Day 26' 0 20 27 19 23 47 42 39 50 
1-99 7 4 5 2 11 7 12 6 
1 OM99 2 0 4 1 2 5 6 1 
>499 1 0 3 2 1 5 4 2 
Day 31 0 17 17 14 23 34 37 31 40 
1-99 11 10 13 5 2 1 18 24 15 
100499 1 3 3 1 4 4 4 4 
>499 2 2 2 1 4 3 4 3 
Day 87 0 25 32 32 29 57 61 57 6 1 
1-99 1 0 0 1 1 1 1 1 
100499 0 0 0 0 0 0 0 0 
>499 1 0 0 0 1 0 1 0 
a Heterogenety among four treatment array (Pc.05). 
Heterogeneity among four treatment array (P<.01). 
Heterogeneity among bolus treatments (P<.05). 
Heterogenety among bolus treatments (P<.01). ' Heterogeneity among AS 700 treatments (P<.10). 
Heterogeneity among AS 700 treatments (Pc.05). 
Heterogeneity among AS 700 treatments (Pc.01). 
TABLE 8. CHI-SQUARE ANALYSIS OF OOCYST SHEDDING 
FREQUENCIES BY AS 700 TREATMENT, TRIAL 2 
Sample Oocyst AS 700 treatment 
date counts/a feces A B C 
Number of animals 
Initial 
Day 0 
Day 3a 
Day 6' 
Day l o b  
Day 13' 
Day 1 7 ~  
Day 1 ga 
Day 24 
TABLE 8 CONTINUED 
Sampie Oocyst AS 700 treatment 
date counts/q feces A B C 
Number of animals 
Day 27a 
Day 31" 0 27 37 34 
1-99 9 2 6 
100499 0 0 0 
>499 0 0 0 
Day 85 
a Heterogeneity among three treatment array (P<.10). 
Heterogeneity among three treatment array (P< .05). 
Heterogenetty among three treatment array (P<.01). 
